Article Text
PDFCommentary
General medicine
There may be a role for addition of rivaroxaban to aspirin in patients with stable coronary artery disease
Statistics from Altmetric.com
Footnotes
Competing interests AB has been an advisory board member for Novo Nordisk and Boehringer Ingelheim.
Patient consent Not required.
Provenance and peer review Commissioned; internally peer reviewed.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.